{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:13:56Z","timestamp":1783710836796,"version":"3.55.0"},"reference-count":65,"publisher":"Xia & He Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,28]]},"DOI":"10.14218\/jcth.2020.00036","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T03:53:31Z","timestamp":1598241211000},"page":"1-11","source":"Crossref","is-referenced-by-count":11,"title":["Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review"],"prefix":"10.14218","volume":"8","author":[{"given":"Sheena","family":"Mago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"key20200824035326_b1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4254\/wjh.v7.i7.926","article-title":"Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy","volume":"7","author":"Purohit","year":"2015","journal-title":"World J Hepatol"},{"key":"key20200824035326_b2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"key20200824035326_b3","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1023\/A:1010620122567","article-title":"A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases","volume":"46","author":"Burak","year":"2001","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"key20200824035326_b4","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/modpathol.3800684","article-title":"Autoimmune liver disease: overlap and outliers","volume":"20","author":"Washington","year":"2007","journal-title":"Mod Pathol"},{"key":"key20200824035326_b5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cld.2014.09.005","article-title":"Diagnosis and management of overlap syndromes","volume":"19","author":"Bunchorntavakul","year":"2015","journal-title":"Clin Liver Dis"},{"key":"key20200824035326_b6","first-page":"266","article-title":"Primary biliary cirrhosis and primary sclerosing cholangitis: a review featuring a women\u2019s health perspective","volume":"2","author":"Marchioni Beery","year":"2014","journal-title":"J Clin Transl Hepatol"},{"key":"key20200824035326_b7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O\u2019Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"key":"key20200824035326_b8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"key20200824035326_b9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/bega.2001.0204","article-title":"Epidemiology of primary sclerosing cholangitis","volume":"15","author":"Schrumpf","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20200824035326_b10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"key20200824035326_b11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2007.01.032","article-title":"Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis","volume":"46","author":"Karlsen","year":"2007","journal-title":"J Hepatol"},{"key":"key20200824035326_b12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20200824035326_b13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2007-1007354","article-title":"Disappearing intrahepatic bile ducts: the syndromes and their mechanisms","volume":"13","author":"Woolf","year":"1993","journal-title":"Semin Liver Dis"},{"key":"key20200824035326_b14","first-page":"893","article-title":"Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies","volume":"90","author":"van Milligen de Wit","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"key20200824035326_b15","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200824035326_b16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1572-0241.2001.03446.x","article-title":"Genetic and familial considerations of primary biliary cirrhosis","volume":"96","author":"Tanaka","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"key20200824035326_b17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arcmed.2014.03.002","article-title":"HLA-DR polymorphism and primary biliary cirrhosis: evidence from a meta-analysis","volume":"45","author":"Li","year":"2014","journal-title":"Arch Med Res"},{"key":"key20200824035326_b18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(03)00501-4","article-title":"Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis","volume":"40","author":"Bogdanos","year":"2004","journal-title":"J Hepatol"},{"key":"key20200824035326_b19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1568-9972(02)00122-2","article-title":"T cell immunity and primary biliary cirrhosis","volume":"2","author":"Ishibashi","year":"2003","journal-title":"Autoimmun Rev"},{"key":"key20200824035326_b20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","article-title":"Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"key20200824035326_b21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10446670310001642429","article-title":"Is there a relation between Chlamydia infection and primary biliary cirrhosis?","volume":"10","author":"Leung","year":"2003","journal-title":"Clin Dev Immunol"},{"key":"key20200824035326_b22","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.14309\/crj.2018.54","article-title":"Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis","volume":"5","author":"Sundaram","year":"2018","journal-title":"ACG Case Rep J"},{"key":"key20200824035326_b23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J. Hepatol"},{"key":"key20200824035326_b24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"key20200824035326_b25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"key20200824035326_b26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5009\/gnl16365","article-title":"Extrahepatic manifestations of primary biliary cholangitis","volume":"11","author":"Chalifoux","year":"2017","journal-title":"Gut Liver"},{"key":"key20200824035326_b27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10067-005-1165-y","article-title":"Association of systemic and thyroid autoimmune diseases","volume":"25","author":"Bir\u00f3","year":"2006","journal-title":"Clin Rheumatol"},{"key":"key20200824035326_b28","first-page":"429","article-title":"Overlapping of primary biliary cirrhosis and small duct primary sclerosing cholangitis: first case report","volume":"4","author":"Oliveira","year":"2012","journal-title":"J Clin Med Res"},{"key":"key20200824035326_b29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.dld.2015.02.002","article-title":"The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis","volume":"47","author":"Floreani","year":"2015","journal-title":"Dig Liver Dis"},{"key":"key20200824035326_b30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.gastrohep.2016.11.010","article-title":"Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report","volume":"40","author":"Mandolesi","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"key20200824035326_b31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-200510000-00011","article-title":"Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective","volume":"17","author":"Kingham","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20200824035326_b32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cld.2008.02.009","article-title":"Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value","volume":"12","author":"Muratori","year":"2008","journal-title":"Clin Liver Dis"},{"key":"key20200824035326_b33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1827.2009.02405.x","article-title":"Liver biopsy in primary biliary cirrhosis: clinicopathological data and stage","volume":"59","author":"Drebber","year":"2009","journal-title":"Pathol Int"},{"key":"key20200824035326_b34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-1","article-title":"Primary biliary cirrhosis","volume":"3","author":"Kumagi","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"key20200824035326_b35","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1515\/cclm-2013-0926","article-title":"The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis","volume":"52","author":"Hu","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"key20200824035326_b36","doi-asserted-by":"crossref","first-page":"8959103","DOI":"10.1155\/2019\/8959103","article-title":"Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis","volume":"2019","author":"Zhang","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"key20200824035326_b37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"key20200824035326_b38","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"key20200824035326_b39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaut.2012.05.022","article-title":"The immunopathology of liver granulomas in primary biliary cirrhosis","volume":"39","author":"You","year":"2012","journal-title":"J Autoimmun"},{"issue":"Suppl 1","key":"key20200824035326_b40","first-page":"43","article-title":"Surgical pathology of the syndrome of primary sclerosing cholangitis","volume":"13","author":"Ludwig","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"key20200824035326_b41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.149.1.6412283","article-title":"Primary sclerosing cholangitis: findings on cholangiography and pancreatography","volume":"149","author":"MacCarty","year":"1983","journal-title":"Radiology"},{"key":"key20200824035326_b42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20200824035326_b43","first-page":"360","article-title":"Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome","volume":"108","author":"Rubel","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"key20200824035326_b44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJGM.S11201","article-title":"Overlap of primary biliary cirrhosis and primary sclerosing cholangitis - a rare coincidence or a new syndrome","volume":"3","author":"Jeevagan","year":"2010","journal-title":"Int J Gen Med"},{"key":"key20200824035326_b45","first-page":"CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"12","author":"Rudic","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200824035326_b46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Par\u00e9s","year":"2000","journal-title":"J Hepatol"},{"key":"key20200824035326_b47","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J Hepatol"},{"key":"key20200824035326_b48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J Hepatol"},{"key":"key20200824035326_b49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"J Hepatol"},{"key":"key20200824035326_b50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"key20200824035326_b51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1365-2036.2006.03155.x","article-title":"Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis","volume":"24","author":"Rautiainen","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key20200824035326_b52","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"key20200824035326_b53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"key20200824035326_b54","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"key20200824035326_b55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"key20200824035326_b56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"key20200824035326_b57","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"key20200824035326_b58","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0002-9270(00)01059-5","article-title":"Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group","volume":"95","author":"van Hoogstraten","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"key20200824035326_b59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J Hepatol"},{"key":"key20200824035326_b60","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology"},{"key":"key20200824035326_b61","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-2000-7708","article-title":"Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group","volume":"32","author":"van den Hazel","year":"2000","journal-title":"Endoscopy"},{"key":"key20200824035326_b62","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1136\/gutjnl-2018-316801","article-title":"Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis","volume":"68","author":"Rupp","year":"2019","journal-title":"Gut"},{"key":"key20200824035326_b63","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/lt.20948","article-title":"Recurrent primary sclerosing cholangitis: Clinical diagnosis and long-term management issues","volume":"12","author":"Gordon","year":"2006","journal-title":"Liver Transpl"},{"key":"key20200824035326_b64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1089-3261(03)00099-0","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"7","author":"MacQuillan","year":"2003","journal-title":"Clin Liver Dis"},{"key":"key20200824035326_b65","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2020.00036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:20Z","timestamp":1783707560000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2020.00036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,24]]},"published-print":{"date-parts":[[2020,9,28]]}},"alternative-id":["10.14218\/JCTH.2020.00036"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2020.00036","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]}}}